Advisory Services Network’s Catalyst Pharmaceutical CPRX Stock Holding History

Advisory Services Network’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,326	Closed	-$57.6K	–	2658
2026 Q1	$57.6K	Buy	+2,326	New	+$55.4K	﹤0.01%	2538
2025 Q4	–	Sell	-2,002	Closed	-$39.4K	–	2306
2025 Q3	$39.4K	Buy	+2,002	New	+$41.2K	﹤0.01%	2576
2024 Q1	–	Sell	-500	Closed	-$8.4K	–	1887
2023 Q4	$8.4K	Buy	+500	New	+$6.83K	﹤0.01%	2934
2023 Q2	–	Sell	-1,801	Closed	-$29.9K	–	1889
2023 Q1	$29.9K	Buy	1,801 +1,301	+260%	+$21.5K	﹤0.01%	2305
2022 Q4	$9.3K	Buy	+500	New	+$7.7K	﹤0.01%	2890
2020 Q4	–	Sell	-400	Closed	-$1K	–	3365
2020 Q3	$1K	Buy	+400	New	+$1.56K	﹤0.01%	3291

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisory Services Network's CPRX Position: Q2 2026 in Review

Advisory Services Network sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 2,326 shares — an estimated $57.6K sold.

Advisory Services Network first reported a position in CPRX in Q3 2020 and held it in 6 quarters. The position peaked at $57.6K in Q1 2026. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Advisory Services Network reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 2,326 Catalyst Pharmaceutical shares in Q2 2026, an estimated $57.6K.
Advisory Services Network first reported a position in Catalyst Pharmaceutical in Q3 2020 and held it in 6 quarters.
Advisory Services Network's Catalyst Pharmaceutical position peaked at $57.6K in Q1 2026.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.